IARC MonDO (IARC Monographs Database Online) Encyclopaedia of Carcinogenic Hazards to Humans, from 1971 to the present IARC MONDO
(IARC Monograph
Database Online)
135 agents
Group 1 — Carcinogenic to humans
1
98 agents
Group 2A — Probably carcinogenic to humans
2A
326 agents
Group 2B — Possibly carcinogenic to humans
2B
499 agents
Group 3 — Not classifiable as to its carcinogenicity to humans
3
Latest Updates
Mar 2026
Meeting 141: Evaluations for Tris(chloropropyl)phosphate (TCPP), Butyraldehyde, Cumyl hydroperoxide
Nov 2025
Meeting 140: Evaluations for Atrazine, Alachlor, Vinclozolin
Bar charts BAR CHARTS
Explore by:
Agent Class Breakdown by Group
Stacked count of agent classes within each IARC Group
Evaluations per Class — coloured by IARC Group
Horizontal stacked bars
Group Proportion per Class
Percentage of Groups 1/2A/2B/3 within each class
Evaluation Count by Classification Group
Bar count of evaluations within each IARC Group
Evaluations
Unique Agents
Group 1 Agents
Database Explorer
View by:
Overall classification
A summary of the evaluation information for each agent given an overall classification by the IARC Monographs. Further details on each agent or evidence stream can be found in the “View by” options above. The “Latest” column indicates whether the row reflects the most recent evaluation (Default filter includes latest and non-latest evaluations). The filters in the sidebar or the text-based filters can be used to restrict to a selection of studies, e.g. only Group 1 agents (The “Reset all filters” option can be used to restore the full list of all agents).
⚠️ Rows where Latest = No indicate earlier evaluations superseded by a more recent one and are displayed with a grey background.
Agent and exposure data
Information for each agent, including the agent class (type of agent), exposure sources, and synonyms (common alternative names).
Evidence for cancer in humans, by cancer type
Evidence for cancer in humans, by cancer type or site, evaluations that were considered to be “Sufficient” or “Limited” at the cancer level stated in the corresponding monograph for each agent (level 1 being broadest and level 4 being most specific). “*See other cancer level” in the “Human evidence” column was added when an evaluation was only made for a related cancer type of a higher or lower cancer level. Users may wish to search at a different cancer level to see the related evaluations for broader or more specific cancer categories related to the cancer type of interest.
Evaluations that were considered to be inadequate for a specific cancer type are not shown, however, these can be found here.
Loading...
Carcinogenicity in experimental animals
Evidence for carcinogenicity in experimental animals for the latest overall evaluations of each agent, including evaluations of compounds which contributed to the evaluation of evidence for carcinogenicity in experimental animals
Mechanistic evidence
For evaluations in IARC Monographs Volume 112 through Volume 123, mechanistic evidence was evaluated according to the 2006 Preamble. For agents in V112-V123, mechanistic evidence in humans was considered strong if the evidence was considered likely to be operative in humans. For evaluations in IARC Monographs Volume 124 onwards, mechanistic evidence was evaluated according to the most recent Preamble (2019).
KC1: Is electrophilic; KC2: Is genotoxic; KC3: Alters DNA repair; KC4: Induces epigenetic alterations; KC5: Induces oxidative stress; KC6: Induces chronic inflammation; KC7: Is immunosuppressive; KC8: Modulates receptor-mediated effects; KC9: Causes immortalization; KC10: Alters cell proliferation/death (see “About” page).
Monograph Volumes Summary
Volume titles, date of publication and meeting, link from which the volume can be downloaded, and number of agents evaluated, by IARC Group (overall classification).
⚠️ For older volumes, the date given is the year of printing. For Volume 115 onwards, the year indicates date of online publication.
About IARC MonDO

The IARC Monographs Programme

The IARC Monographs programme was established in 1971 to identify environmental factors that are carcinogenic hazards to humans. These include chemicals, complex mixtures, occupational exposures, physical agents, biological agents, and lifestyle factors. An expert working group convened by the IARC Monographs programme assesses the strength of the available evidence that an agent can cause cancer in humans, based on three streams of evidence: studies with cancer end-points in humans, studies with cancer end-points in experimental animals, and studies with mechanistic end-points (in humans, humans primary cells, and experimental systems). In addition, the working group characterizes exposure to each agent.

Read more: https://monographs.iarc.who.int/

IARC MonDO database: the Encyclopaedia of Carcinogenic Hazards to Humans

The IARC Monographs Database Online (IARC MonDO) organizes information on all the agents that have been evaluated by the IARC Monographs programme. IARC MonDO allows users to search, including the overall evaluation for each agent, agent class (type) and exposure sources, evidence for cancer in humans (including by cancer type), evidence for cancer in experimental animals, and mechanistic evidence (including on the key characteristics of carcinogens). An additional database view option allows users to find information on each volume of the IARC Monographs , and includes a link to download the volumes.

A range of filters (including by IARC group and agent class) is available in a filter sidebar, on the left-hand side of the database page, that operates across the different table views. As some agents have been evaluated more than once, there is also an option to restrict the database search results to the most recent evaluation for each agent. Note that this option has been applied automatically to the human cancer, animal cancer, and mechanistic section tables, because the database has been populated with this information only for the latest evaluation of each agent. The “Reset all filters” option can be used to restore the full list of all agents. The “Reset column filters” option can be used to clear restrictions based on the text search options above each column.

The data from the database, after applying the selected filters, can be downloaded into CSV, XLSX, or PDF format.

Data Visualization

The data visualization section allows users to create customizable charts and to download the List of classifications by cancer site. Soon users will be able to use more customizable options for charts and heat maps and will be able to download reports for each agent according to overall evaluation, agent class, or evidence stream.

Copyright Notice

Information on copyright can be found here: https://www.iarc.who.int/copyright-notice/

Preamble to the IARC Monographs

The Preamble to the IARC Monographs describes the objectives and scope of the programme, the scientific principles and procedures used in developing a monograph, the types of evidence considered, and the scientific criteria that guide the evaluations. The Preamble should be consulted when exploring the database or reading a list of evaluations or monograph.

The current Preamble was adopted in 2019 and applies from Volume 124 onwards. Previous versions of the Preamble can be found here: https://monographs.iarc.who.int/previous-preamble/

IARC Group

In the IARC Monographs evaluation process, each agent is assigned to one of four groups ( “Classification group” ). For agents evaluated from Volume 124 onwards (under the most recent Preamble), the following Table 1 provides guidance on the possible combinations of evidence required for an agent to be assigned to a particular evaluation group.

Table 1. Combinations of evidence required for an agent to be assigned to a particular IARC Group

Evaluation (IARC Group) Evidence for cancer in humans Evidence for cancer in experimental animals Mechanistic evidence
Carcinogenic to humans
(Group 1)
Sufficient Irrelevant Irrelevant
Limited or inadequate Sufficient Strong (exposed humans)
Probably carcinogenic to humans
(Group 2A)
Limited Sufficient Limited or inadequate
Limited Limited or inadequate Strong
Inadequate Sufficient Strong (human cells or tissues)
Limited or inadequate Irrelevant Strong (mechanistic class)
Possibly carcinogenic to humans
(Group 2B)
Limited Limited or inadequate Limited or inadequate
Inadequate Sufficient Limited or inadequate
Inadequate Limited or inadequate Strong
Not classifiable as to its carcinogenicity to humans
(Group 3)
Inadequate Sufficient Strong (does not operate in humans)
All other situations

Agent Class

For the purposes of the database, each agent was assigned to at least one “Agent class” indicating the nature of the agent or exposure. These included: Biological; Chemical; Complex exposure; Dust, particle, or fibre; Metal or metalloid; Pharmaceutical; Physical agent; Occupation; or Personal habit.

Key Characteristics of Carcinogens

Since the revision to the Preamble in 2019, the mechanistic evidence for each agent has been evaluated according to the 10 key characteristics of carcinogens framework ( Smith et al., 2016 ). The evidence for each key characteristic is considered individually ( “Mechanistic KC” ) (see Table 2 below) and combined to reach an overall mechanistic evaluation ( “Mechanistic evidence” ) of strong , moderate , limited , weak , or inadequate .

Table 2. The 10 Key Characteristics of Carcinogens

KC Key characteristic of carcinogens
KC1 Is electrophilic or can be metabolically activated to an electrophile
KC2 Is genotoxic
KC3 Alters DNA repair or causes genomic instability
KC4 Induces epigenetic alterations
KC5 Induces oxidative stress
KC6 Induces chronic inflammation
KC7 Is immunosuppressive
KC8 Modulates receptor-mediated effects
KC9 Causes immortalization
KC10 Alters cell proliferation, cell death, or nutrient supply

For some agents, a “Mechanistic qualifier” was applied, which indicates instances in which the overall classification was assigned using supporting evidence from mechanistic or other relevant data. This can include upgrades, downgrades, or instances where the agent was considered to be part of a mechanistic class of agents.

Funding

The IARC Monographs are supported by grants from:

  • United States National Cancer Institute (since 1982)
  • European Commission, Directorate-General for Employment, Social Affairs and Inclusion (since 1986, and since 2014 from the European Union Programme for Employment and Social Innovation, EaSI )
  • United States National Institute of Environmental Health Sciences (since 1992).

Suggested citation

IARC (2026). IARC MonDO (IARC Monographs Database Online). Version 20260709 [online database]. Lyon, France: International Agency for Research on Cancer. Available from: https://mondo.iarc.who.int/ .

Disclaimer

This is a preliminary version of the database, which will be updated and optimized regularly. Although great care is taken, mistakes may be present. If you find an error, or would like to share your feedback and suggestions, please contact us at imo@iarc.who.int .

Build 2026-07-17-disc-exports

Trace Cancer sites to Exposure sources to Agents

Search or select a cancer type below. The exposure sources and the agents linked to that cancer type are then shown side by side.

Cancer sites
Exposure sources
×
Agents
×